Table 1.
Descriptive analysis of demographic characteristics, sexual health risk factors, and receipt of preventive care in AYA women aged 12 to 24 years
| All (N = 408) | Hormonal Contraception (N = 226) | No Contraception or Condoms only (N = 182) | P-valuea | |
|---|---|---|---|---|
| Any Insurance | 397 (97.3%) | 217 (96.0%) | 180 (98.9%) | 0.74 |
| Public Insurance | 337 (82.6%) | 182 (80.5%) | 155 (85.2%) | 0.22 |
| Race: | 0.19 | |||
| African American | 386 (94.6%) | 215 (95.1%) | 171 (94.0%) | |
| Caucasian | 14 (3.4%) | 9 (4.0%) | 5 (2.7%) | |
| Other | 8 (2.0%) | 2 (0.9%) | 6 (3.3%) | |
| Presentation for: | ||||
| Any Visit | 339 (83.1%) | 203 (89.8%) | 136 (74.7%) | <0.05 |
| Preventive Visit | 190 (46.6%) | 119 (52.7%) | 71 (39.0%) | <0.05 |
| Immunizations | 350 (85.8%) | 198 (87.6%) | 152 (83.5%) | 0.10 |
| Sexually Active | 294 (72.1%) | 205 (90.7%) | 89 (48.9%) | <0.05 |
| Among sexually active AYA women, history of: | ||||
| Prior Pregnancy | 78 (26.5%) | 61 (29.8%) | 17 (19.1%) | 0.57 |
| Prior STI | 135 (45.9%) | 99 (48.3%) | 36 (40.4%) | 0.22 |
| GC/CT Screen | 201 (68.4%) | 149 (72.7%) | 52 (58.4%) | <0.05 |
| HIV Screen | 161 (54.8%) | 118 (57.6%) | 43 (48.3%) | 0.13 |
GC/CT = Neisseria gonorrhoeae/Chlamydia trachomatis; HIV = human immunodeficiency virus; LARC = long-acting reversible contraception; MARC = medium-acting reversible contraception; SARC= short-acting reversible contraception; STI = sexually transmitted infection.
a
P values reported from chi-square tests.